FerGene Company
FerGene is an new Gene therapy, spin off Ferring Pharmaceuticals. has been created to potentially commercialize nadofaragne firadenovec in the US and to advance the global clinical development.
Technology:
Neurological Disorders
Industry:
Gene Therapy
Headquarters:
Vaud
Founded Date:
2019
Funding Status:
Private Equity
Estimated Revenue:
$1M to $10M
Register and Claim Ownership